What are the common organisms responsible for Community-Acquired Pneumonia (CAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Organisms Responsible for Community-Acquired Pneumonia

Streptococcus pneumoniae remains the single most common bacterial pathogen causing CAP across all age groups and severity levels, accounting for approximately 10-41.7% of identified cases. 1, 2

Primary Bacterial Pathogens

Most Common

  • Streptococcus pneumoniae is consistently the predominant pathogen, representing the most frequent cause in outpatients, hospitalized patients, and ICU admissions, with rates of 10-41.7% depending on diagnostic methods used 1, 2
  • Haemophilus influenzae (predominantly nontypeable strains) is the second most common bacterial cause, particularly in patients with underlying chronic bronchopulmonary disease, accounting for 4-14% of cases 1, 2

Atypical Pathogens

  • Mycoplasma pneumoniae causes 4-39% of CAP cases overall, with higher rates (13-37%) in outpatient settings 1, 2, 3
  • Chlamydophila pneumoniae accounts for 0-20% of cases, with higher prevalence in older children and adults 1, 2
  • Legionella pneumophila represents 0-12.5% of cases, more common in severe CAP requiring ICU admission 1

Less Common Bacterial Causes

  • Moraxella catarrhalis occurs in 1-3% of cases, primarily in patients with chronic lung disease 1, 2
  • Staphylococcus aureus (including MRSA) causes severe CAP particularly during or following influenza outbreaks, with MRSA prevalence up to 3% in CAP patients 1
  • Enteric gram-negative bacteria (Pseudomonas aeruginosa, Enterobacteriaceae) found in up to 2-6% of cases, typically in patients with structural lung disease, prior antibiotics, corticosteroid use, or septic shock on admission 1

Viral Pathogens

Viruses account for 14-35% of CAP cases in adults and are increasingly recognized as major contributors, often occurring as co-infections with bacteria. 1

  • Influenza virus is the predominant viral cause, accounting for 4-30% of cases depending on season 1
  • Respiratory syncytial virus (RSV) is particularly common in children but also affects adults 1
  • Rhinovirus identified in up to 8% of severe CAP cases 1
  • Other viruses include parainfluenza, adenovirus, metapneumovirus, coronavirus (including SARS-CoV-2), and herpes viruses 1

Age-Specific Patterns

Children

  • Viruses predominate in children under 5 years, accounting for 14-35% of cases, with RSV being most common 1
  • Streptococcus pneumoniae remains the leading bacterial cause, detected in 5-37% depending on diagnostic methods (blood culture 5-10%, serologic testing 16-37%) 1
  • Mycoplasma pneumoniae increases with age: 15% in children under 5 years versus 42% in children over 5 years 1, 4
  • Haemophilus influenzae accounts for approximately 5% of pediatric CAP 1

Adults and Elderly

  • Streptococcus pneumoniae dominates across all adult age groups 1, 2
  • Risk for gram-negative pathogens increases with advanced age, comorbidities, and prior healthcare exposure 1, 2

Severe CAP (ICU-Level Disease)

In patients requiring ICU admission, the pathogen distribution shifts:

  • Streptococcus pneumoniae still most common at 41.7% overall incidence, representing over 80% of bacteremic cases 1
  • Viral pathogens identified in 22% of severe CAP, often with bacterial co-infection 1
  • Staphylococcus aureus, Legionella species, and gram-negative bacilli are encountered more frequently than in non-severe CAP 1

Critical Diagnostic Limitations

The causative pathogen remains unidentified in 20-60% of CAP cases despite comprehensive diagnostic testing. 1, 2, 3

  • Blood or pleural fluid cultures for S. pneumoniae are positive in only 5-10% of cases 1
  • Mixed infections (viral-bacterial or multiple bacterial pathogens) occur in 8-40% of cases 1, 2
  • Post-influenza bacterial superinfection carries up to 10% mortality, most commonly with S. pneumoniae, S. aureus, or H. influenzae 1

Risk Factor-Based Pathogen Prediction

Specific Risk Factors for Resistant or Unusual Pathogens

  • Pseudomonas aeruginosa risk factors: structural lung disease (bronchiectasis), corticosteroid use, recent broad-spectrum antibiotics (>7 days in past month), septic shock on presentation 1
  • MRSA risk factors: prior MRSA infection/colonization, recurrent skin infections, severe pneumonia, recent influenza 1
  • Aspiration pneumonia: anaerobic coverage only indicated with witnessed aspiration event, loss of consciousness, alcohol/drug overdose, seizures, or esophageal motility disorders 1

Common Pitfalls to Avoid

  • Do not assume anaerobic coverage is routinely needed for CAP; it is only indicated in classic aspiration syndromes with documented risk factors 1
  • Do not overlook viral etiologies, particularly influenza, which can present as primary viral pneumonia or predispose to severe bacterial superinfection 1
  • Do not rely solely on blood cultures for S. pneumoniae diagnosis, as they are positive in only 5-10% of cases despite pneumococcus being the most common pathogen 1
  • Consider drug-resistant S. pneumoniae in areas with high macrolide resistance (up to 33% in some regions) when selecting empiric therapy 5
  • Recognize that normal respiratory flora on culture does not exclude bacterial pneumonia, as high-quality sputum samples are rarely obtained before antibiotics are started 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bacterial Pneumonia Causes and Pathogens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Mycoplasma pneumoniae Pneumonia: Incidence and Diagnostic Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Community-Acquired Pneumonia in Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.